Women with Gynecological Cancers Receiving Specialized Ambulatory Palliative Care (SAPV).

IF 2.4 4区医学 Q2 OBSTETRICS & GYNECOLOGY

Geburtshilfe Und Frauenheilkunde Pub Date : 2025-01-23 eCollection Date: 2025-04-01 DOI:10.1055/a-2489-4730

Johannes Maximilian Just, Marie-Therese Schmitz, Ulrike Nitz, Katharina Ladermann, Ulrich Grabenhorst

{"title":"Women with Gynecological Cancers Receiving Specialized Ambulatory Palliative Care (SAPV).","authors":"Johannes Maximilian Just, Marie-Therese Schmitz, Ulrike Nitz, Katharina Ladermann, Ulrich Grabenhorst","doi":"10.1055/a-2489-4730","DOIUrl":null,"url":null,"abstract":"Background: A dignified final phase of life spent at home is what many people with terminal cancer wish for. There are currently no studies with large datasets on the palliative care of patients with gynecological tumors in the home environment.Material and methods: Data from 5487 patients with gynecological-oncological disease who received specialized outpatient palliative care (SAPV) between 2017 and 2021 were included in the analysis.Results: The analysis showed that 88.8% of the patients died in a home environment and that their symptom burden remained stable or even decreased slightly during treatment. The median duration of active SAPV was 23 days. Factors such as age, comorbidities, and symptom burden at the start of treatment influenced the survival time of patients. The SAPV team and relatives who provided care in the home environment were mostly very satisfied with the care provided.Conclusion: The study provides important insights into the palliative care of patients with gynecological tumors and underscores the importance of SAPV for dignified end-of-life care.","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"85 4","pages":"434-442"},"PeriodicalIF":2.4000,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11968136/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Geburtshilfe Und Frauenheilkunde","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2489-4730","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: A dignified final phase of life spent at home is what many people with terminal cancer wish for. There are currently no studies with large datasets on the palliative care of patients with gynecological tumors in the home environment.

Material and methods: Data from 5487 patients with gynecological-oncological disease who received specialized outpatient palliative care (SAPV) between 2017 and 2021 were included in the analysis.

Results: The analysis showed that 88.8% of the patients died in a home environment and that their symptom burden remained stable or even decreased slightly during treatment. The median duration of active SAPV was 23 days. Factors such as age, comorbidities, and symptom burden at the start of treatment influenced the survival time of patients. The SAPV team and relatives who provided care in the home environment were mostly very satisfied with the care provided.

Conclusion: The study provides important insights into the palliative care of patients with gynecological tumors and underscores the importance of SAPV for dignified end-of-life care.

查看原文本刊更多论文

妇科癌症妇女接受专科门诊姑息治疗（SAPV）。

背景：有尊严地在家中度过生命的最后阶段是许多癌症晚期患者的愿望。目前还没有关于家庭环境下妇科肿瘤患者姑息治疗的大数据集研究。材料和方法：2017年至2021年期间接受专科门诊姑息治疗（SAPV）的5487例妇科肿瘤患者的数据被纳入分析。结果：分析显示，88.8%的患者在家庭环境中死亡，治疗期间症状负担保持稳定甚至略有下降。有效SAPV的中位持续时间为23天。年龄、合并症和治疗开始时的症状负担等因素影响患者的生存时间。SAPV团队和在家庭环境中提供护理的亲属大多对所提供的护理非常满意。结论：本研究为妇科肿瘤患者的姑息治疗提供了重要的见解，并强调了SAPV对有尊严的临终关怀的重要性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Geburtshilfe Und Frauenheilkunde 医学-妇产科学

CiteScore

2.50

自引率

22.20%

发文量

828

审稿时长

6-12 weeks

期刊介绍： Geburtshilfe und Frauenheilkunde (GebFra) addresses the whole field of obstetrics and gynecology and is concerned with research as much as with clinical practice. In its scientific section, it publishes original articles, reviews and case reports in all fields of the discipline, namely gynecological oncology, including oncology of the breast obstetrics and perinatal medicine, reproductive medicine, and urogynecology. GebFra invites the submission of original articles and review articles. In addition, the journal publishes guidelines, statements and recommendations in cooperation with the DGGG, SGGG, OEGGG and the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF, Association of Scientific Medical Societies, www.awmf.org). Apart from the scientific section, Geburtshilfe und Frauenheilkunde has a news and views section that also includes discussions, book reviews and professional information. Letters to the editors are welcome. If a letter discusses an article that has been published in our journal, the corresponding author of the article will be informed and invited to comment on the letter. The comment will be published along with the letter.